Found: 37
Select item for more details and to access through your institution.
Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer.
- Published in:
- Radiation Oncology, 2015, v. 10, n. 1, p. 1, doi. 10.1186/s13014-015-0351-6
- By:
- Publication type:
- Article
Proctitis following stereotactic body radiation therapy for prostate cancer.
- Published in:
- Radiation Oncology, 2014, v. 9, n. 1, p. 223, doi. 10.1186/s13014-014-0277-4
- By:
- Publication type:
- Article
Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer.
- Published in:
- Radiation Oncology, 2014, v. 9, n. 1, p. 1, doi. 10.1186/1748-717X-9-148
- By:
- Publication type:
- Article
Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer.
- Published in:
- Radiation Oncology, 2014, v. 9, n. 1, p. 1, doi. 10.1186/1748-717X-9-52
- By:
- Publication type:
- Article
Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Obstructive voiding symptoms following stereotactic body radiation therapy for prostate cancer.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Potency preservation following stereotactic body radiation therapy for prostate cancer.
- Published in:
- Radiation Oncology, 2013, v. 8, n. 1, p. 1, doi. 10.1186/1748-717X-8-256
- By:
- Publication type:
- Article
Potency preservation following stereotactic body radiation therapy for prostate cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Ten-Year Single Institutional Analysis of Geographic and Demographic Characteristics of Patients Treated With Stereotactic Body Radiation Therapy for Localized Prostate Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.616286
- By:
- Publication type:
- Article
Management of Isolated Local Failures Following Stereotactic Body Radiation Therapy for Low to Intermediate Risk Prostate Cancer.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.551491
- By:
- Publication type:
- Article
Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer in Men With a High Baseline International Prostate Symptom Score (IPSS ≥ 15).
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.01060
- By:
- Publication type:
- Article
Urinary Morbidity in Men Treated With Stereotactic Body Radiation Therapy (SBRT) for Localized Prostate Cancer Following Transurethral Resection of the Prostate (TURP).
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2020.00555
- By:
- Publication type:
- Article
intensity-Modulated radiation Therapy with stereotactic Body radiation Therapy Boost for Unfavorable Prostate cancer: a report on 3-Year Toxicity.
- Published in:
- Frontiers in Oncology, 2017, v. 7, p. 1, doi. 10.3389/fonc.2017.00005
- By:
- Publication type:
- Article
Proctitis 1 Week after Stereotactic Body Radiation Therapy for Prostate Cancer: Implications for Clinical Trial Design.
- Published in:
- Frontiers in Oncology, 2016, p. 1, doi. 10.3389/fonc.2016.00167
- By:
- Publication type:
- Article
Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction.
- Published in:
- Frontiers in Oncology, 2016, p. 1, doi. 10.3389/fonc.2016.00122
- By:
- Publication type:
- Article
Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: The Georgetown University Experience.
- Published in:
- Frontiers in Oncology, 2016, p. 1, doi. 10.3389/fonc.2016.00114
- By:
- Publication type:
- Article
Urethrogram-directed stereotactic body radiation therapy for clinically localized prostate cancer in patients with contraindications to magnetic resonance imaging.
- Published in:
- Frontiers in Oncology, 2015, p. 1, doi. 10.3389/fonc.2015.00194
- By:
- Publication type:
- Article
Dysuria following stereotactic body radiation therapy for prostate cancer.
- Published in:
- Frontiers in Oncology, 2015, p. 1, doi. 10.3389/fonc.2015.00151
- By:
- Publication type:
- Article
Stereotactic body radiation therapy for prostate cancer: what is the appropriate patient-reported outcome for clinical trial design?
- Published in:
- Frontiers in Oncology, 2015, v. 5, p. 1, doi. 10.3389/fonc.2015.00077
- By:
- Publication type:
- Article
Improved irritative voiding symptoms 3 years after stereotactic body radiation therapy for prostate cancer.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00290
- By:
- Publication type:
- Article
Clinical characteristics and management of late urinary symptom flare following stereotactic body radiation therapy for prostate cancer.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00122
- By:
- Publication type:
- Article
Suivi des indicateurs qualité pour la recherche de mycobactéries dans les laboratoires de biologie médicale.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Early biochemical outcomes following neoadjuvant/adjuvant relugolix with stereotactic body radiation therapy for intermediate to high risk prostate cancer.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1289249
- By:
- Publication type:
- Article
Predictors of acute urinary symptom flare following stereotactic body radiation therapy (SBRT) in the definitive treatment of localized prostate cancer.
- Published in:
- Acta Oncologica, 2017, v. 56, n. 8, p. 1136, doi. 10.1080/0284186X.2017.1299221
- By:
- Publication type:
- Article
Translation-dependent mechanisms lead to PML upregulation and mediate oncogenic K-RAS-induced cellular senescence.
- Published in:
- EMBO Molecular Medicine, 2012, v. 4, n. 7, p. 594, doi. 10.1002/emmm.201200233
- By:
- Publication type:
- Article
Self-Reported Burden in Elderly Patients With Localized Prostate Cancer Treated With Stereotactic Body Radiation Therapy (SBRT).
- Published in:
- Frontiers in Oncology, 2020, v. 9, p. 1, doi. 10.3389/fonc.2019.01528
- By:
- Publication type:
- Article
Self-Reported Burden in Elderly Patients With Localized Prostate Cancer Treated With Stereotactic Body Radiation Therapy (SBRT).
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2019.01528
- By:
- Publication type:
- Article
Patient-Reported Financial Burden Following Stereotactic Body Radiation Therapy for Localized Prostate Cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.852844
- By:
- Publication type:
- Article
Treatment Interruptions During Stereotactic Body Radiotherapy for Prostate Cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.796496
- By:
- Publication type:
- Article
Bleeding Risk Following Stereotactic Body Radiation Therapy for Localized Prostate Cancer in Men on Baseline Anticoagulant or Antiplatelet Therapy.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.722852
- By:
- Publication type:
- Article
(S009) Intensity-Modulated Radiation Therapy With Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: A Report on Three-Year Toxicity.
- Published in:
- Oncology (08909091), 2016, p. 5
- By:
- Publication type:
- Article
Evaluation of Four Fully Integrated Molecular Assays for the Detection of Respiratory Viruses during the Co-Circulation of SARS-CoV-2, Influenza and RSV.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 14, p. 3942, doi. 10.3390/jcm11143942
- By:
- Publication type:
- Article
Prognostic utility of biopsy-based PTEN and ERG status on biochemical progression and overall survival after SBRT for localized prostate cancer.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1381134
- By:
- Publication type:
- Article
Intensity modulated radiation therapy with stereotactic body radiation therapy boost for unfavorable prostate cancer: five-year outcomes.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1240939
- By:
- Publication type:
- Article
Utilization of Patient-Reported outcomes to Guide symptom Management during stereotactic Body Radiation therapy for Clinically Localized Prostate Cancer.
- Published in:
- Frontiers in Oncology, 2017, p. 1, doi. 10.3389/fonc.2017.00227
- By:
- Publication type:
- Article
Prostate-specific antigen 5 Years following stereotactic Body radiation Therapy for low- and intermediate-risk Prostate cancer: an ablative Procedure?
- Published in:
- Frontiers in Oncology, 2017, p. 1, doi. 10.3389/fonc.2017.00157
- By:
- Publication type:
- Article